Literature DB >> 19724735

Dysthymic disorder: forlorn and overlooked?

Randy A Sansone1, Lori A Sansone.   

Abstract

This ongoing column is dedicated to the challenging clinical interface between psychiatry and primary care-two fields that are inexorably linked.Dysthymic disorder is a smoldering mood disturbance characterized by a long duration (at least two years in adults) as well as transient periods of normal mood. The disorder is fairly common in the US general population (3-6%) as well as in primary care (7%) and mental health settings (up to one-third of psychiatric outpatients). While the etiology of dysthymia remains unknown, there appears to be a genetic susceptibility, which may manifest in the presence of various psychosocial stressors. While the Diagnostic and Statistical Manual of Mental Disorders diagnostic criteria are fairly clear, the disorder can be easily under-recognized for a variety of reasons. Treatment may include pharmacotherapy and psychotherapy, although the overall treatment course is oftentimes characterized by protracted symptoms and relapses.

Entities:  

Keywords:  depression; dysthymia; dysthymic disorder; mood disorder

Year:  2009        PMID: 19724735      PMCID: PMC2719439     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  37 in total

1.  Five-year course and outcome of dysthymic disorder: A prospective, naturalistic follow-up study.

Authors:  D N Klein; J E Schwartz; S Rose; J B Leader
Journal:  Am J Psychiatry       Date:  2000-06       Impact factor: 18.112

2.  Predicting the 2 1/2-year outcome of dysthymic disorder: the roles of childhood adversity and family history of psychopathology.

Authors:  C E Durbin; D N Klein; J E Schwartz
Journal:  J Consult Clin Psychol       Date:  2000-02

3.  Accuracy of diagnosing depression in primary care: the impact of chronic somatic and psychiatric co-morbidity.

Authors:  Jasper Nuyen; Anita C Volkers; Peter F M Verhaak; François G Schellevis; Peter P Groenewegen; Geertrudis A M Van den Bos
Journal:  Psychol Med       Date:  2005-08       Impact factor: 7.723

4.  Dysthymia. Psychotherapists and patients confront the high cost of "low-grade" depression.

Authors: 
Journal:  Harv Ment Health Lett       Date:  2005-02

Review 5.  Pharmacotherapy of dysthymia: a review.

Authors:  R H Howland
Journal:  J Clin Psychopharmacol       Date:  1991-04       Impact factor: 3.153

6.  Outcome of dysthymic disorder at 5-year follow-up: the effect of familial psychopathology, early adversity, personality, comorbidity, and chronic stress.

Authors:  E P Hayden; D N Klein
Journal:  Am J Psychiatry       Date:  2001-11       Impact factor: 18.112

7.  Adding group psychotherapy to medication treatment in dysthymia: a randomized prospective pilot study.

Authors:  D J Hellerstein; S A Little; L W Samstag; S Batchelder; J C Muran; M Fedak; D Kreditor; R N Rosenthal; A Winston
Journal:  J Psychother Pract Res       Date:  2001

Review 8.  Antidepressants: partial response in chronic depression.

Authors:  J Fawcett
Journal:  Br J Psychiatry Suppl       Date:  1994-12

9.  Platelet MAO activity in patients with dysthymic disorder.

Authors:  J Tripodianakis; M Markianos; D Sarantidis; G Spyropoulou; V Taktikou; E Bistolaki
Journal:  Psychiatry Res       Date:  1998-05-08       Impact factor: 3.222

10.  [One year prevalence of mental disorders comorbidity and associated socio-demographic risk factors in the general population of Spain. Results of the ESEMeD-Spain study].

Authors:  J Autonell; F Vila; A Pinto-Meza; G Vilagut; M Codony; J Almansa; P E Muñoz; J V Torres; J Alonso; J M Haro
Journal:  Actas Esp Psiquiatr       Date:  2007-09       Impact factor: 1.196

View more
  3 in total

1.  Evidence for neuroplastic compensation in the cerebral cortex of persons with depressive illness.

Authors:  R Bansal; D J Hellerstein; B S Peterson
Journal:  Mol Psychiatry       Date:  2017-03-07       Impact factor: 15.992

2.  Commentary: Parental Depressive Symptoms as a Predictor of Outcome in the Treatment of Child Internalizing and Externalizing Problems.

Authors:  Talha Tahir; Alameen Damer; Michael Wong
Journal:  Front Psychiatry       Date:  2019-07-26       Impact factor: 4.157

3.  Anxiety and Depression Comorbidities in Moroccan Patients With Breast Cancer.

Authors:  Ouassil El Kherchi; Amina Aquil; Noureddine El Khoudri; Mustapha Mouallif; Mohamed Daghi; Maroua Guerroumi; El Madani Saad; Abdellatif Benider; Arumugam R Jayakumar; Abdeljalil Elgot
Journal:  Front Psychiatry       Date:  2021-01-12       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.